These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
483 related items for PubMed ID: 14609838
1. Globe conserving treatment of the only eye in bilateral retinoblastoma. Lee V, Hungerford JL, Bunce C, Ahmed F, Kingston JE, Plowman PN. Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838 [Abstract] [Full Text] [Related]
2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO. Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [Abstract] [Full Text] [Related]
3. Vitreoretinal complications of retinoblastoma treatment. Tawansy KA, Samuel MA, Shammas M, Murphree AL. Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679 [Abstract] [Full Text] [Related]
4. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G. Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802 [Abstract] [Full Text] [Related]
5. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG. Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578 [Abstract] [Full Text] [Related]
6. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ. Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863 [Abstract] [Full Text] [Related]
7. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Chan MP, Hungerford JL, Kingston JE, Plowman PN. Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423 [Abstract] [Full Text] [Related]
8. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009). Lumbroso-Le Rouic L, Savignoni A, Levy-Gabriel C, Aerts I, Cassoux N, Salviat F, Gauthier-Villars M, Freneaux P, Brisse H, Dendale R, Esteve M, Doz F, Desjardins L. J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136 [Abstract] [Full Text] [Related]
9. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related]
10. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy. Shields CL, Say EA, Pointdujour-Lim R, Cao C, Jabbour PM, Shields JA. J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423 [Abstract] [Full Text] [Related]
12. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma]. Balwierz W, Kobylarz J, Starzycka M, Dluzniewska A. Med Wieku Rozwoj; 2001 Dec; 5(3 Suppl 1):15-23. PubMed ID: 12004148 [Abstract] [Full Text] [Related]
13. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors. Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, Shields JA. Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158 [Abstract] [Full Text] [Related]
14. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT. Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771 [Abstract] [Full Text] [Related]
15. Focal stereotactic external beam radiotherapy as a vision-sparing method for the treatment of peripapillary and perimacular retinoblastoma: preliminary results. Sahgal A, Millar BA, Michaels H, Jaywant S, Chan HS, Heon E, Gallie B, Laperriere N. Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):628-34. PubMed ID: 17051954 [Abstract] [Full Text] [Related]
16. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor? Gombos DS, Cauchi PA, Hungerford JL, Addison P, Coen PG, Kingston JE. Br J Ophthalmol; 2006 Sep; 90(9):1168-72. PubMed ID: 16707528 [Abstract] [Full Text] [Related]
17. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Wilson MW, Haik BG, Liu T, Merchant TE, Rodriguez-Galindo C. Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999 [Abstract] [Full Text] [Related]